InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 09/13/2019 12:20:27 PM

Friday, September 13, 2019 12:20:27 PM

Post# of 675
News: $EARS Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program

Hamilton, Bermuda, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has obtained...

Read the whole news EARS - Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program